| Serial Number | 79285070 |
| Word Mark | BRIGHT PEAK |
| Filing Date | Wednesday, March 25, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 11, 2022 |
| Registration Number | 6610085 |
| Registration Date | Tuesday, January 11, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 26, 2021 |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; medical and veterinary preparations, namely, recombinant or chemically synthesized and optimized proteins; preparations for destroying vermin; fungicides, herbicides; biotechnological preparations, namely, recombinant or chemically synthesized and optimized proteins for medical use; enzymes for medical use; enzymes for veterinary use; biological and chemical reagents for medical or veterinary use; amino acids for medical use; amino acids for veterinary use; peptides for medical or veterinary use, namely, for the treatment of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; proteins for medical or veterinary use, namely, recombinant or chemically synthesized and optimized proteins for detection and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, nutritional diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; pharmaceutical preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical compositions and preparations for cancer prevention and treatment; pharmaceutical preparations for treatment of autoimmune and inflammatory diseases; pharmaceutical preparations for treatment of skin diseases; pharmaceutical preparations for treatment of neurodegenerative, metabolic and ophthalmological diseases |
| Goods and Services | Scientific and technological services, namely, scientific research, scientific analysis, and scientific testing in the field of biotechnology and new product research and design services relating thereto; research and development in the field of biotechnology; consulting services in the field of biotechnology; scientific research services in the field of proteins, peptides and antibodies, and scientific advice relating thereto; scientific research services for medical purposes in the field of cancer and autoimmune diseases and scientific advice relating thereto |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 8, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 8, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bright Peak Therapeutics AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Bright Peak Therapeutics AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Bright Peak Therapeutics AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Event Date | Event Description |
| Monday, July 18, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, June 23, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, June 22, 2022 | FINAL DISPOSITION PROCESSED |
| Monday, April 11, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, January 11, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, November 4, 2021 | NOTIFICATION PROCESSED BY IB |
| Wednesday, November 3, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, October 26, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 26, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 13, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 13, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, October 6, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 6, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, October 6, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, September 17, 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, September 17, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 24, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 24, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 24, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 24, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, July 29, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 29, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 27, 2021 | ASSIGNED TO LIE |
| Thursday, July 22, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, July 22, 2021 | EX PARTE APPEAL-INSTITUTED |
| Thursday, July 22, 2021 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Thursday, July 22, 2021 | EXPARTE APPEAL RECEIVED AT TTAB |
| Tuesday, January 26, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, January 26, 2021 | FINAL REFUSAL E-MAILED |
| Tuesday, January 26, 2021 | FINAL REFUSAL WRITTEN |
| Wednesday, January 6, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 5, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 5, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 7, 2020 | REFUSAL PROCESSED BY IB |
| Thursday, July 23, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, July 23, 2020 | REFUSAL PROCESSED BY MPU |
| Thursday, June 18, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, June 17, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 16, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, May 12, 2020 | APPLICATION FILING RECEIPT MAILED |
| Friday, May 8, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, May 7, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |